Consensus Alignment Healthcare, Inc.

Equities

ALHC

US01625V1044

Real-time Estimate Cboe BZX 01:35:17 2024-06-10 pm EDT 5-day change 1st Jan Change
8.215 USD -1.50% Intraday chart for Alignment Healthcare, Inc. +3.07% -4.36%

Evolution of the average Target Price on Alignment Healthcare, Inc.

Price target over the last 5 years

History of analyst recommendation changes

2.oCzXUcOEFX_7Kw8kZRuy21ES2KWVCLM1XNpq8MYTw9M.8lmuEqbjIRezfEh1SH2CuAInspL2UN1sO51HiqtpiJvtXZMgls1iDax9Ow~a9bab3b7d705245ef0998ead37d4d625
BofA Securities Upgrades Alignment Healthcare to Buy From Neutral, Raises Price Target to $11 From $7.75 MT
Baird Initiates Alignment Healthcare With Outperform Rating, $10 Price Target MT
Piper Sandler Upgrades Alignment Healthcare to Overweight From Neutral MT
UBS Adjusts Price Target on Alignment Healthcare to $6.50 From $8.50, Maintains Neutral Rating MT
Stifel Adjusts Alignment Healthcare's Price Target to $9 From $11, Maintains Buy Rating MT
Piper Sandler Downgrades Alignment Healthcare to Neutral From Overweight, Adjusts Price Target to $6 From $12 MT
UBS Adjusts Alignment Healthcare Price Target to $8.50 From $9, Maintains Neutral Rating MT
Stifel Starts Coverage on Alignment Healthcare with Buy Rating, $11 Price Target MT
Stephens Adjusts Price Target on Alignment Healthcare to $10.50 From $9, Keeps Equalweight Rating MT
UBS Adjusts Alignment Healthcare Price Target to $9 From $6.50, Maintains Neutral Rating MT
BofA Securities Downgrades Alignment Healthcare to Neutral From Buy MT
Raymond James Upgrades Alignment Healthcare to Strong Buy From Outperform, Adjusts Price Target to $10 From $9 MT
Stephens Initiates Coverage on Alignment Healthcare with Equalweight Rating, $9 Price Target MT
Morgan Stanley Adjusts Alignment Healthcare's Price Target to $12 From $19, Keeps Overweight Rating MT
UBS Adjusts Alignment Healthcare Price Target to $6 From $8, Maintains Neutral Rating MT
JPMorgan Adjusts Price Target on Alignment Healthcare to $10 From $12, Maintains Neutral Rating MT
UBS Adjusts Alignment Healthcare Price Target to $8 From $10, Maintains Neutral Rating MT
Raymond James Upgrades Alignment Healthcare to Outperform From Market Perform, Price Target is $9 MT
Goldman Sachs Adjusts Alignment Healthcare Price Target to $12 From $14, Maintains Buy Rating MT
Goldman Sachs Adjusts Price Target on Alignment Healthcare to $14 From $21, Maintains Buy Rating MT
Piper Sandler Adjusts Price Target on Alignment Healthcare to $12 From $19, Maintains Overweight Rating MT
UBS Adjusts Alignment Healthcare's Price Target to $10 From $16, Maintains Neutral Rating MT
JPMorgan Downgrades Alignment Healthcare to Neutral From Overweight, Adjusts Price Target to $12 From $22 MT
Raymond James Downgrades Alignment Healthcare to Market Perform From Outperform MT
UBS Adjusts Alignment Healthcare Price Target to $16 From $17, Maintains Neutral Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
8.34 USD
Average target price
8.5 USD
Spread / Average Target
+1.92%
High Price Target
11 USD
Spread / Highest target
+31.89%
Low Price Target
4.5 USD
Spread / Lowest Target
-46.04%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Alignment Healthcare, Inc.

BofA Securities
Baird
Piper Sandler
UBS
Stifel Nicolaus
Stephens Inc.
Raymond James
Morgan Stanley
JPMorgan Chase
Goldman Sachs
Cowen
Barclays
SVB Leerink
William Blair & Co.
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock Market
  2. Equities
  3. ALHC Stock
  4. Consensus Alignment Healthcare, Inc.